Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
11/2010
11/10/2010EP1616183B1 Methods of detecting neurological disorders
11/10/2010EP1487483B1 Chimeric infectious dna clones of porcine circovirus and uses thereof
11/10/2010EP1471788B1 Methods of inducing differentiation in stem cells, methods of generating tissue using scaffold matrices derived from micro-organs and stem cells, methods of producing adult stem cells and methods of continuously generating stem cells by implantation of micro-organs as sources of stem cells
11/10/2010EP1265915B1 Novel compounds
11/10/2010EP1030867B1 Mammalian milk growth factor
11/10/2010EP1015477B1 32 Human secreted proteins
11/10/2010EP0920517B1 Dna sequence useful for the production of polyhydroxyalkanoates
11/10/2010EP0852622B1 Flowering genes
11/10/2010CN201626960U Perfusion device for stem cell culture
11/10/2010CN1925741B Animal genotyping method
11/10/2010CN1775946B Enhanced virus-mediated DNA transfer
11/10/2010CN1747753B Cell sheets for ectocornea formation, method of producing the same and method of using the same
11/10/2010CN101883868A Mutated acetohydroxyacid synthase genes in brassica
11/10/2010CN101883850A Methods and compositions for inactivating alpha-1,6 fucosyltransferase (FUT 8) gene expression
11/10/2010CN101883845A Engineered dendritic cells and uses for the treatment of cancer
11/10/2010CN101883844A Method and kit for rapid isolation of human foxp3+ treg cells
11/10/2010CN101883793A Anti-idiotypic antibodies which neutralise the inhibitory activity of an inhibitory antibody directed against the C1 domain of factor VIII
11/10/2010CN101883792A New antibodies specific of the beta-amyloid peptides and their uses as diagnostic agents or drugs
11/10/2010CN101880681A Preparation method of maltooligosyltrehalose hydrolase gene sequence and recombinant protein thereof
11/10/2010CN101880680A Gene for coding beta-glucosaccharase and application thereof
11/10/2010CN101880679A Thermophilic streptomycetes maltose alpha-amylase gene and application thereof
11/10/2010CN101880678A Mangrove betaine aldehyde dehydrogenase gene and application thereof
11/10/2010CN101880677A siRNA sequence against 2009 new influenza A virus polymerase gene and nucleoprotein gene and application thereof
11/10/2010CN101880675A High-level expression of tetanus toxin receptor binding domain Hc in Escherichia coli and application
11/10/2010CN101880670A 植物血红蛋白 Plants hemoglobin
11/10/2010CN101880668A Gene for coding serpin and application thereof
11/10/2010CN101880667A RNAi plant expression vector of ABA (Abscisic Acid) 8'-hydroxylase gene and application
11/10/2010CN101880657A Promoter molecules for use in plants
11/10/2010CN101880648A Primary culture method for pancreas acinar cells
11/10/2010CN101880328A Th multi-epitope gene and fusion protein of cryptosporidium parvum and application thereof
11/10/2010CN101880325A Monoclonal antibody for detecting imidacloprid pesticide residue
11/10/2010CN101880324A Monoclonal antibody of anti-human SIRPalpha, cell strain, preparation method and application thereof
11/10/2010CN101880318A Virus protein granules of hepatitis E virus-4 ORF2 fragment and prepration method and application thereof
11/10/2010CN101879329A Artificial skin containing basilar membrane and construction method thereof
11/10/2010CN101878757A Methods and compositions for enhancing vascular access
11/10/2010CN101603039B Chitinase capable of degrading spore walls of myxosporean and encoding genes thereof
11/10/2010CN101422619B New method for preventing tumor cell growth based on nucleus binding-protein gene silencing
11/10/2010CN101392234B Method for producing valerian iridoids
11/10/2010CN101269091B Method for preparing holothurian embryotrophy freeze-dried powder
11/10/2010CN101161055B Method for exsomatizing screening grassiness salt resistsomatic mutation body
11/10/2010CN101124892B Cymbidium edaphic orchids seed aseptic seeding growing seedlings method
11/09/2010US7829764 Soybean variety XB28M08
11/09/2010US7829761 Scarecrow-like stress-related polypeptides and methods of use in plants
11/09/2010US7829759 Generation of plants with improved pathogen resistance
11/09/2010US7829687 comprising an N-terminal domain derived from E. coli FkpA that allows for dimerization and provides a substrate binding region, and a C-terminal thioredoxin domain derived from E. coli DsbA
11/09/2010US7829685 Regulation of kinase, regulated in COPD kinase (RC kinase)
11/09/2010US7829683 Polynucleotides encoding modified HIV-1 gp41 membrane polypeptides
11/09/2010US7829676 Whitefly ecdysone receptor antibody
11/09/2010US7829675 TWEAK receptor
11/09/2010US7829672 Modulation of sodium channels in dorsal root ganglia
11/09/2010US7829546 applying an acid solution to the metal oxide substrate; mixing a solution containing the fine particles ( Au, Ag, Pt etc.) with a solution containing a self-organizing material (DNA, RNA, protein, Sugar, lipid); applying the mixed solution to the substrate after removing the acid solution, then drying
11/09/2010US7829545 Bladder and lower urinary tract syndromes, particularly, irrative symptoms, and to a method of treating same using alpha 1d-adrenergic receptor ( alpha 1dAR) antagonists. The invention further relates to a method of screening compounds
11/09/2010US7829536 administering to a patient with lymphedema a therapeutically effective amount of a vascular endothelial growth factor D (VEGF-D) protein at the site of edema, that binds and stimulates wild-type VEGFR-3; genetic disorders; screening
11/09/2010US7829529 Use of factor VIIa or a tissue factor antagonist for regulating gene expression and cell migration or chemotaxis
11/09/2010US7829526 DNA encoding peptide, an antibody against the peptide; cardioinhibitory, hypotensive agent; peptide as an active ingredient; marker protein, peptide tag
11/09/2010US7829338 Dominant negative alleles of human mismatch repair genes introduced into cells and transgenic animals; prepared more efficiently than by relying on the natural rate of mutation
11/09/2010US7829337 contains an aminated polyrotaxane in which at least some of hydroxy groups in the cyclodextrin structure are each substituted with a substituent having an amino group;
11/09/2010US7829336 Method for isolating a self-renewing, multipotent, slow-cycling cell
11/09/2010US7829335 Inducing mesenchymal stem cells to osteoblasts by translocating biological clock-relevant factors(cryptochrome) from cytoplasm to cells' nucleus; laser light activation of cellular differentiation
11/09/2010US7829334 preparation of myotube cells 80% of which have a sarcomere structure; having high insulin responsiveness; culturing myoblast cells, differentiation-inducing the myotube cells into the myoblast cells in a culture medium with a high content of amino acids, applying an electric pulse to the myotube cells
11/09/2010US7829333 Modulation of hedgehog-mediated signaling pathway
11/09/2010US7829332 inhibiting differentiation of progenitor or glial cells using G protein coupled receptor agonists and antagonists; treatment of neurdegenerative diseases; antitumor agents
11/09/2010US7829331 Use of urea-adjuvated polypeptides for diagnosis, prophylaxis and treatment
11/09/2010US7829325 Drug testing with bio-artificial organ slices including for example those derived from liver
11/09/2010US7829310 Compositions of aminoacyl-tRNA synthetase and uses thereof
11/09/2010US7829308 Neurogenin
11/09/2010US7829304 2-Amino-2-benzoyl-1-acetoxy-3-hydroxy- or 3-acetoxypropane tumor suppressor reactivators: 3-Acetoxy-2-(acetoxymethyl)-1-oxo-1-phenylpropan-2-ammonium chloride
11/09/2010US7829302 used to detect the specificity of activated lymphocytes in recipients or patients after organ transplantation or being infected by pathogenic microorganism or vaccination
11/09/2010US7829294 antibody against a soluble fibrin, which does not react with fibrinogen but specifically recognizes a conformation-changed site newly occurred in a C-terminal region of an A alpha -chain of the soluble fibrin formed through thrombin digestion of fibrinogen; disseminated intravascular coagulation
11/09/2010US7829290 Method and device for protein delivery into cells
11/09/2010US7829103 immunogenic composition consisting of, as an active principle, a pure methylated heparin-binding hemagglutinin (HBHA) protein in a pharmaceutically acceptable formulation, and one or more adjuvants
11/09/2010US7829095 Produced by hybridoma cell line DSM ACC 2533
11/09/2010US7829092 Recombinant anti-VLA4 antibody molecules
11/09/2010US7829089 Antibody to mammalian cytokine-like polypeptide-10
11/09/2010US7829083 protein comprising signal transduction domain for use in treatment and prevention of nervous system disorders; immunizing a mammal with a protein comprising the sequence of SEQ ID NO:2
11/09/2010US7829078 Drug delivery; sustained, high-level expression of a delivered nucleotide sequence encoding erythropoietin, and for in vivo secretion thereof from transduced muscle cells such that systemic delivery; increasing the hematocrit and/or the reticulocyte count in a mammalian subject
11/09/2010CA2412493C Purging of cells using viruses
11/09/2010CA2362794C Inhibitors of separase, method for identifying them and uses
11/09/2010CA2319759C Transgenic crops accumulating fructose polymers and methods for their production
11/09/2010CA2223532C Monkey monoclonal antibodies specific to human b7.1 and/or b7.2 primatized forms, pharmaceutical compositions
11/09/2010CA2161684C Bioactive and/or targeted dendrimer conjugates
11/09/2010CA2137815C Dna sequences used in the production of recombinant human bssl/cel in transgenic non-human mammals, and the produced bssl/cel used in infant formulas
11/04/2010WO2010127367A2 Human gastrointestinal stem cell-derived primary intestinal epithelial cell system and methods of use thereof
11/04/2010WO2010127342A2 Method of preparing autologous cells and method of use for therapy
11/04/2010WO2010127275A1 Method of expanding human hepatocytes in vivo
11/04/2010WO2010127119A2 Multiphasic microfibers for spatially guided cell growth
11/04/2010WO2010126389A1 Process for treating neural stem cells based on ampakines and/or other modulators of ionotropic glutamate receptors, compositions thereof and their use in cns conditions
11/04/2010WO2010126278A2 Humanized nsg mouse, method of producing the same and use thereof
11/04/2010WO2010126139A1 Protein-type electron mediator
11/04/2010WO2010126081A1 Method for solubilizing insoluble protein and/or peptide
11/04/2010WO2010125620A1 Method for inducing degradation of protein in mammalian cell
11/04/2010WO2010125527A1 Method for production of anti-tumor trail protein
11/04/2010WO2010125110A1 Method for obtaining human microglial precursor cells from pluripotent stem cells
11/04/2010WO2010125107A1 Microglial precursor cells for the treatment of malignant neoplasms of the central nervous system
11/04/2010WO2010124655A1 Complex microcapsule comprising epiphyseal plate chondrocytes and preparation method and use thereof
11/04/2010WO2010124585A1 Methods and apparatuses for isolating and preparing stem cells
11/04/2010WO2010124530A1 Use of histone deacetylase gene oshdt1 in enhancing rice heterosis
11/04/2010WO2010124498A1 A resistance-screened tumor stem cell, its antigen composition, an anti-tumor dendritic cell loading with said antigens, their preparation methods, uses and kits thereof as well as a dendritic cell vaccine
11/04/2010WO2010124365A1 Compositions and methods for modulating stem cells and uses thereof
11/04/2010WO2010065927A3 Dna-damage-induced proteolysis
1 ... 437 438 439 440 441 442 443 444 445 446 447 448 449 450 451 452 453 454 455 456 457 ... 1827